Postpartum Weight Loss and Exercise (PRIDE)
Status: | Completed |
---|---|
Conditions: | Endocrine, Diabetes |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 18 - 45 |
Updated: | 2/27/2019 |
Start Date: | February 2011 |
End Date: | December 2017 |
Early Postpartum Treatment of Gestational Diabetes With Weight Loss and Exercise
The overall objective of this pilot project is to test in 50 women with a history of
gestational diabetes mellitus (GDM), the effectiveness and feasibility of an 8 month
intensive lifestyle intervention to reduce the rate of metabolic abnormalities within 1 year
after delivery.
gestational diabetes mellitus (GDM), the effectiveness and feasibility of an 8 month
intensive lifestyle intervention to reduce the rate of metabolic abnormalities within 1 year
after delivery.
The objective is in comparison to a group of women not enrolled in the lifestyle
intervention, 8 months of intensive lifestyle intervention aimed at promoting 7% weight loss
through increased physical activity and dietary modification in women with a history of GDM
will:
1. decrease body weight and
2. reduce the rate of metabolic abnormalities, 12 months after delivery
intervention, 8 months of intensive lifestyle intervention aimed at promoting 7% weight loss
through increased physical activity and dietary modification in women with a history of GDM
will:
1. decrease body weight and
2. reduce the rate of metabolic abnormalities, 12 months after delivery
Inclusion Criteria:
- Women are required to be enrolled (provided written consent for participation) in the
COPSS-GDM study and therefore have met the following inclusion criteria:
- Postpartum Women ≥18 years to 45 years (inclusive) of age who experienced GDM
during index pregnancy
- English-speaking
Exclusion Criteria:
- Exclusion Criteria:
- Women enrolled in COPSS-GDM will be excluded if they met the following criteria:
Medical Exclusion Criteria
- History or clinical manifestation of any other significant metabolic, hematologic,
pulmonary, cardiovascular, gastrointestinal, neurologic, immune, hepatic, renal,
urologic disorders, or cancer
- Regular use of medications for weight control or psychosis
- Current use of medication to treat diabetes Psychiatric and Behavioral Exclusion
Criteria
- History or clinical manifestation of any eating disorder
- Smoking
- History of drug or alcohol abuse (up to 14 drinks a week are allowed) within the past
two years Other Exclusion Criteria
- Pregnancy or pregnancy planned during the coming year
- Unwilling or unable to adhere to the clinical evaluation schedule over the twelve
-month study period
We found this trial at
1
site
6400 Perkins Rd
Baton Rouge, Louisiana 70808
Baton Rouge, Louisiana 70808
(225) 763-2500
Principal Investigator: Leanne M. Redman, RhD
Phone: 225-763-2759
Pennington Biomedical Research Center Unlike other medical research facilities where science occurs in separate labs...
Click here to add this to my saved trials